Celyad

13 email addresses found for celyad.com
{first}.{l}@celyad.com
13 email addresses
http://businesswire.com/news/home/20150903006348/en/celyad-announces-appointment-dr.-debasish-roychowdhury-independent September 9, 2018
http://businesswire.com/news/home/20180508006284/fr September 9, 2018
http://businesswire.com/news/home/20180522006077/en/celyad-announces-closing-global-offering November 11, 2018
http://businesswire.com/news/home/20180731005869/fr October 10, 2018
http://businesswire.com/news/home/20180806005476/fr September 9, 2018
http://celyad.com/en/nouvelles/celyad-annonce-les-resultats-de-l-etude-clinique-de-phase-iii-chart-1-evaluant-sa-therapie-cellulaire-c-cure August 8, 2018
http://celyad.com/fr/news/celyad-announces-results-for-the-chart-1-phase-iii-clinical-trial-evaluating-c-cure-cell-therapy August 8, 2018
http://celyad.com/fr/nouvelles/celyad-annonce-les-resultats-de-l-etude-clinique-de-phase-iii-chart-1-evaluant-sa-therapie-cellulaire-c-cure August 8, 2018
http://cnbc.com/2015/09/04/globe-newswire-celyad-announces-the-appointment-of-dr-debasish-roychowdhury-as-independent-director.html January 1, 2018
http://cnbc.com/2015/12/23/globe-newswire-celyad-to-address-us-institutional-investors-in-january-at-jp-morgan-healthcare-conference.html August 8, 2018
http://cnbc.com/2016/09/09/globe-newswire-celyad-sa-celyad-completes-the-nkr-2-phase-i-trial-with-successful-safety-follow-up-of-the-fourth-dose-level.html August 8, 2018
http://cnbc.com/2016/09/15/globe-newswire-celyad-sa-celyad-ceo-to-present-at-the-2016-cell-gene-meeting-on-the-mesa.html February 2, 2018
http://cnbc.com/2016/11/07/globe-newswire-celyads-nkr-2-phase-i-safety-trial-delivers-encouraging-results-to-be-presented-at-ash-2016.html September 9, 2018
http://consilium-comms.com/news-insights/client-news/client-news/2017/celyad-initiates-second-dose-escalation-in-think-trial-in-first-us-patient October 10, 2018
http://consilium-comms.com/news-insights/client-news/client-news/2017/first-complete-response-in-a-relapsed-refractory-aml-patient-in-the-think-trial October 10, 2018
http://daniel933.rssing.com/chan-8095239/all_p1536.html November 11, 2018
http://firstwordpharma.com/node/1566364 September 9, 2018
http://itespresso.fr/press-release/celyad-annonce-la-nomination-du-dr-debasish-roychowdhury-en-qualit-dadministrateur-indpendant September 9, 2018
http://itespresso.fr/press-release/celyad-annonce-les-rsultats-de-ltude-clinique-de-phase-iii-chart-1-valuant-sa-thrapie-cellulaire-c-cure September 9, 2018
http://itespresso.fr/press-release/celyad-conclut-avec-succs-le-suivi-de-scurit-30-jours-de-la-premire-cohorte-de-patients-de-ltude-de-phase-i-car-t-nkg2d September 9, 2018
http://itespresso.fr/press-release/celyad-publie-son-rapport-dactivit-du-troisime-trimestre2015 August 8, 2018
http://itespresso.fr/press-release/celyad-traite-le-premier-patient-de-la-seconde-cohorte-de-son-tude-de-phasei-car-t-nkg2d September 9, 2018
http://kingdom854.rssing.com/chan-7124883/all_p1368.html September 9, 2018
http://regulatorynews.co.uk/finance/stocks/celyad/news/786063.html September 9, 2018
http://regulatorynews.co.uk/finance/stocks/celyad/news/786071.html September 9, 2018
http://regulatorynews.co.uk/finance/stocks/celyad/news/786801.html September 9, 2018
http://webdisclosure.fr/finance/stocks/celyad/news/762833.html September 9, 2018
http://webdisclosure.fr/finance/stocks/celyad/news/786799.html September 9, 2018
http://wire.chartoperator.com/finance/stocks/celyad/news/786073.html October 10, 2018
http://wire.chartoperator.com/finance/stocks/celyad/news/786799.html October 10, 2018
http://benzinga.com/pressreleases/18/07/g12061525/celyad-announces-fda-acceptance-of-ind-application-for-cyad-101-a-firs November 11, 2018
http://biowin.org/biowin/fr/membres/238-cardio3-biosciences.html April 4, 2018
http://businesswire.com/news/home/20180212006132/en/celyad-host-key-opinion-leader-meeting-car-t August 8, 2018
http://businesswire.com/news/home/20180322006222/en/celyad-reports-2017-financial-operating-results-expected July 7, 2018
http://businesswire.com/news/home/20180322006223/fr August 8, 2018
http://businesswire.com/news/home/20180328006196/en/celyad-present-updates-cyad-01-american-association-cancer July 7, 2018
http://businesswire.com/news/home/20180328006197/fr August 8, 2018
http://celyad.com/en/newsroom August 8, 2017
http://celyad.com/en/newsroom-1 August 8, 2018
http://celyad.com/fr/newsroom August 8, 2018
http://celyad.com/fr/newsroom-1 August 8, 2018
http://celyad.com/newsroom July 7, 2017
http://consilium-comms.com/news-insights/client-news/client-news/2017/celyad-announces-third-quarter-2017-business-update October 10, 2018
http://consilium-comms.com/news-insights/client-news/client-news/2017/first-complete-response-in-a-relapsed-refractory-aml-patient-in-the-think-trial July 7, 2018
http://finanzwire.com/finance/stocks/celyad/news/762831.html October 10, 2018
http://finanzwire.com/finance/stocks/celyad/news/786063.html October 10, 2018
http://finanzwire.com/finance/stocks/celyad/news/786071.html October 10, 2018
http://finanzwire.com/finance/stocks/celyad/news/786801.html October 10, 2018
http://firstwordpharma.com/node/1566364 September 9, 2018
http://kingdom854.rssing.com/chan-7124883/all_p1368.html September 9, 2018
http://regulatorynews.co.uk/finance/stocks/celyad/news/786063.html September 9, 2018
http://regulatorynews.co.uk/finance/stocks/celyad/news/786071.html September 9, 2018
http://regulatorynews.co.uk/finance/stocks/celyad/news/786799.html October 10, 2018
http://regulatorynews.co.uk/finance/stocks/celyad/news/786801.html September 9, 2018
http://webdisclosure.fr/finance/stocks/celyad/news/762833.html September 9, 2018
http://webdisclosure.fr/finance/stocks/celyad/news/786065.html October 10, 2018
http://webdisclosure.fr/finance/stocks/celyad/news/786073.html October 10, 2018
http://webdisclosure.fr/finance/stocks/celyad/news/786799.html September 9, 2018
http://wire.chartoperator.com/finance/stocks/celyad/news/786073.html October 10, 2018
http://wire.chartoperator.com/finance/stocks/celyad/news/786799.html October 10, 2018
http://alliancerm.org/member/celyad January 1, 2016
http://businesswire.com/news/home/20150505006360/fr December 12, 2017
http://cnbc.com/2015/05/05/globe-newswire-cardio3-biosciences-announces-results-of-annual-shareholder-assembly-2015-and-confirmation-of-name-change-to-celyad.html September 9, 2018
http://cnbc.com/2015/05/18/globe-newswire-celyad-announces-filing-of-registration-statement-in-the-united-states-for-a-proposed-global-offering.html March 3, 2018
http://cnbc.com/2015/05/19/globe-newswire-celyad-announces-first-quarter-2015-business-update.html March 3, 2018
http://cnbc.com/2015/06/24/globe-newswire-celyad-announces-closing-of-its-global-offering.html November 11, 2018
http://cnbc.com/2015/11/10/globe-newswire-celyad-successfully-completes-30-day-safety-follow-up-of-first-patient-cohort-in-nkg2d-car-t-cell-phase-i-trial.html November 11, 2017
http://globenewswire.com/news-release/2015/05/05/732304/10132690/en/cardio3-biosciences-announces-results-of-annual-shareholder-assembly-2015-and-confirmation-of-name-change-to-celyad.html March 3, 2016
http://globenewswire.com/news-release/2015/05/05/732304/10132690/en/Cardio3-BioSciences-Announces-Results-of-Annual-Shareholder-Assembly-2015-and-Confirmation-of-Name-Change-to-Celyad.html June 6, 2015
http://globenewswire.com/news-release/2015/05/19/737362/10135167/en/celyad-announces-first-quarter-2015-business-update.html March 3, 2016
http://itespresso.fr/press-release/celyad-annonce-le-dpt-public-dun-prospectus-denregistrement-f-1-en-vue-dune-introduction-en-bourse-aux-tats-unis January 1, 2018
Show more results
3 more results for celyad.com. Sign up or log in to access the full and uncovered results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 1,000,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about celyad.com

Industry: Science

Language of the website: English

Main technologies used: